- B. Braun Launches ACCEL®: Pioneering Interventional Systems
- MiRus Siegel ™ TAVR: First in Human Results Presented at New York Valves
- Applied Medical Technology Launches IntelAir™, a Nasopharyngeal Airway
- Nuclera Awarded £1.14M Innovate UK Funding for Development of eProtein Discovery
- CERo Therapeutics Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
Signia Integrated Xperience Hearing Aid Platform Named a Winner of the 2024 BIG Innovation Awards
he new Signia Integrated Xperience hearing aid platform was recognized in the Healthcare category. Past BIG Innovation Award winners include Citi Ventures, Walgreens Boots Alliance, Velcro®, Bloomfire, and Colgate-Palmolive.
Censis Technologies Achieves HITRUST Implemented, 1-year (i1) Certification to Manage Data Protection and Mitigate Cybersecurity Threats
Certification validates Censis Technologies is operating leading security practices to support protection of sensitive information.
Medtronic Diabetes REPORTS World’s 1st Approval for MiniMed™ 780G System with Simplera Sync™ Disposable, All-in-one Sensor
Que Dallara, EVP and President, Medtronic Diabetes comments….
“We’re incredibly proud that the MiniMed™ 780G system continues to be the most widely used automated insulin delivery system in Europe since we launched it in 2020. Real-world data on over 100,000 users on the system across many geographies and cultures shows that when using recommended settings the system is delivering an average Time in Range of nearly 80%, raising the bar on what ‘good’ looks like.”
Medtronic Receives CE Mark for its Next Generation Micra Leadless Pacing Systems
Micra AV2 and Micra VR2, the world’s smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers, while still delivering the many benefits of leadless pacing such as reduced complications compared to traditional pacemakers reports Medtronic.
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Orthonika Awarded £1.34 Million Innovate UK Grant
“There is currently no widely available treatment solution that allows patients to return to a pain-free active lifestyle following meniscectomy,” said Maria Kristina Bartolo, Ph.D., Chief Technology Officer at Orthonika. “We are delighted that Innovate UK has recognised the potential for our novel total meniscus replacement to fulfill a significant unmet clinical need and further promote joint preservation.”
Dr Peter Staats, Chief Medical Officer at National Spine and Pain, Joins the Neuralace Medical Advisory Board
Dr Peter Staats brings extensive expertise to the company and will collaborate with the advisory board and Neuralace Medical to contribute valuable insights and strategic guidance.
Industry Expert Byline
Reimagining CRM: What’s Next for Medtech Commercial Success | By Akshay Kapadia, CEO and Founder, Conexus Solutions, Inc.
Success depends on more than just choosing the right CRM platform; it requires aligning that platform with optimized business processes, a clear data strategy, and long-term commercial goals. When all of these elements work together, the CRM platform becomes a powerful tool to support growth, innovation, and sustained value.
Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink® Target Platform
The addition of Olink to the Synexa Life Sciences technology portfolio demonstrates our continued commitment to strengthening our biomarker and bioanalysis capabilities across several expertise areas including oncology, immuno-oncology, infectious diseases and more.
Oncuria Bladder Cancer Tests Receive Medicare Coverage Effective January 1, 2024 | Reports DiaCarta
Oncuria Bladder Cancer Tests, developed by Nonagen Bioscience and validated by DiaCarta as a Lab Developed Test (LDT), at its CAP-accredited and CLIA-certified laboratory, have received Medicare coverage effective January 1, 2024.
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
Medtronic to Acquire Affera
The acquisition expands the Medtronic portfolio of advanced cardiac ablation products and accessories to meet physician needs within a growing patient population.
DIT Acquires Lifeline PICC
Peter Harris, President & Chief Executive Officer of DIT, commented that “bringing Lifeline PICC and Kathy into our growing family will contribute to our continued success.
FDA Medical Device Updates
Our Experts - Byline Articles
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
Phillips-Medisize Teams with GlucoModicum to Develop an Innovative Needle-Free Continuous Glucose Monitor
GlucoModicum is an innovative medtech company based in Finland, to design and eventually commercialize a proprietary non-invasive, wearable device that removes technology and patient-care roadblocks to continuous glucose monitoring (CGM).
